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Background: Endovascular brachytherapy (EBT) has been shown to prevent restenosis after percutaneous transluminal
coronary angioplasty (PTA) in both animal and clinical studies. However, as yet, the effect of EBT on peripheral arteries
is unknown.
Objective: This intravascular ultrasound scan (IVUS) study evaluates the effect of EBT on the extent of plaque growth and
vascular remodeling after PTA of the femoropopliteal artery.
Methods: Twenty-four patients with obstructive disease of the femoropopliteal artery underwent standard PTA. Patients
were randomized to receive no additional therapy or additional EBT (192-Iridium) after PTA. IVUS investigation was
performed after PTA and at 6-month follow-up. A comparison was made between patients without EBT (n  16) and
with EBT (n  8) in the change in lumen, vessel, and plaque area and plaque dissections seen with IVUS at 6-month
follow-up.
Results: At follow-up, IVUS revealed a significant difference in lumen area change between patients without and with
EBT (9% and23%, respectively; P .03). This difference was the result of a significant difference in vessel area change
(2% and 19%, respectively; P  .05). In both groups of patients, a similar increase in plaque area (12% and 16%,
respectively; P  .80) was encountered. Plaque dissections encountered immediately after PTA were absent at follow-up
in patients without EBT, whereas in four of the eight patients with EBT, a persistent dissection was encountered.
Conclusion: This randomized IVUS study showed that -radiation after PTA has a positive effect on lumen dimensions
at 6-month follow-up by inducing positive vascular remodeling (ie, vascular dilatation); -radiation seemed not to affect
plaque growth. In addition, -radiation has an effect on the healing process of dissections after PTA. (J Vasc Surg 2002;
36:318-24.)
Percutaneous transluminal angioplasty (PTA) is in
common use for revascularization of obstructive disease of
femoropopliteal arteries. However, restenosis continues to
be the main problem of this intervention, with reported
restenosis in as many as 80% of patients at 1-year follow-
up.1-4 Intravascular ultrasound scan (IVUS) studies have
shown that the restenosis process after PTA was the result
of both plaque growth (ie, intimal proliferation) and vas-
cular constriction.5-9
To diminish the vascular response to intervention, en-
dovascular brachytherapy (EBT) has been proposed. The
effective use of EBT in prevention of intimal proliferation in
animal models after balloon arterial injury has been shown
in preclinical studies with histology as gold standard.10-13
Similarly, angiographic and clinical evidence exist that EBT
reduces restenosis after both PTA14-19 and stent placement
of coronary arteries.18,20-25 However, as yet, the effect of
EBT on vascular remodeling is unknown. The aim of this
randomized study was to determine the effect of EBT on
the extent of plaque growth and vascular remodeling 6
months after PTA of the femoropopliteal artery with IVUS.
METHODS
Study group. Four hospitals participated in this mul-
ticenter trial, named VARA (VAscular RAdiotherapy). Be-
tween September 1998 and August 2000, 38 patients (24
men; median age, 65 years; range, 44 to 85 years) with
disabling claudication were recruited. Entry criteria in-
cluded angiographically proven femoropopliteal arterial
stenosis (50% diameter stenosis) or occlusion, lesion
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length of less than 10 cm, patients aged 40 to 85 years, and
no inflow obstruction or significant stenosis in the iliac
artery. Exclusion criteria included impaired renal function
(serum creatinine level, 160 mol/L), acute ischemia,
pregnancy, and life expectancy less than 12 months. The
study was approved by the local Committee on Human
Research. Patients were included in the study after in-
formed consent was given.
Procedure. All patients underwent a standard PTA
procedure. Patients were randomized to PTA only or to
PTA with additional EBT. Randomization was performed
per center and was stratified for stenosis or occlusion and
for lesions of less than 3 cm or from 3 to 10 cm. Heparin
(5000 IU intravenously) was given at the onset of the
procedure, and additional heparin (5000 IU intravenously)
was given in case of EBT because of the delay between the
two interventions. After intervention, patients underwent
standard oral anticoagulation therapy (Aspirin 100 mg
daily) for at least 1 year.
Intravascular ultrasound scan. IVUS was performed
after successful angiographic PTA (diameter stenosis,
50%). A guidewire-tipped 4.3F catheter (Jomed, Ules-
traten, The Netherlands; 0.035) with a single rotating
ultrasound element (30 MHz) was used. The IVUS cathe-
ter was advanced over a guidewire beyond the lesion ante-
gradely through a 7F sheath in the ipsilateral femoral artery.
The guidewire then was removed, and a manual pull-back
of the IVUS catheter was performed. The location of the
IVUS catheter tip was documented with fluoroscopy, a
radiopaque ruler, and a displacement sensing device.26 The
latter device documents the location of the catheter tip in
relation to the patella in steps of 0.01 cm during the
pull-back maneuver.26 The catheter tip position was docu-
mented together with the IVUS images on the monitor,
and the resulting images were stored on an S-VHS video-
tape for offline analysis.
Radiation therapy. Immediately after the IVUS study
was performed, radiation was given in those patients ran-
domized for EBT with an over-the-wire delivery catheter.
Radiation was performed in the department of radiotherapy
under supervision of a radiotherapist. A specially designed
EBT centering catheter (Nucletron, Veenendaal, The
Netherlands) was used, which ensures optimal dose distri-
bution over the vessel wall. The catheter was connected
with a computerized afterloader, microSelectron HDR
with an Iridium-192 radioactive source. Dose distribution
was calculated on the basis of the post-PTA angiographic
lumen diameter at the level of the target lesion and the
length of the dilated segment with an additional 1 cm at
both the proximal and distal ends. The actual length of
irradiation equaled the length of the dilated segment (max-
imal 11 cm) plus 1.5 cm proximal and distal, so that the
100% isodose reaches 1 cm beyond the proximal and distal
ends; this was performed with a standard procedure. The
prescribed dosage must be applied to the adventitia. Dis-
tance from the source axis to the adventitia was defined as the
radius of the dilated vessel lumen plus 2 mm. In practice,
this means that this distance corresponded with the diam-
eter of the EBT catheter balloon divided by 2 and plus 2
mm.
A dose of 14 Gy was delivered at the prescribed points
along the length of the dilated segment at a previously
defined distance from the source axis. Actual irradiation was
applied with the 192-Iridium source, which was computer-
guided to traverse the entire dilated segment in 5-mm steps
moving from distal to proximal. After treatment, the cath-
eter was removed after emptying the EBT centering bal-
loon.
Follow-up. The follow-up protocol included single-
plane angiography and IVUS imaging 6 months after in-
tervention. The angiograms obtained at follow-up were
scored for lumen diameter stenosis by an independent
radiologist blinded to EBT data. Angiographic restenosis of
the vascular segment subjected to PTA was defined as
50% diameter stenosis. If a 50% diameter stenosis was
involved at the reference segment (ie, the segment proximal
or distal to the dilated vascular segment), it was considered
as a de novo stenosis.
The IVUS procedure was performed in the same man-
ner as described previously. With the information of the
displacement sensing device, the radiopaque ruler, and the
anatomic markers, such as side branches and typical shaped
calcifications, the IVUS cross sections obtained immedi-
ately after PTA and at follow-up were matched. The dis-
placement sensing device has proven to give highly accurate
information on the position of the catheter tip, thus en-
abling accurate matching of the IVUS cross sections.26 To
ensure that the IVUS cross sections obtained after interven-
tion corresponded with those that were obtained at fol-
low-up examination, the cross sections were studied side-
by-side and frame-to-frame. Matched IVUS cross sections
obtained from the treated site and from the nondilated
reference site were selected with 1-cm interval for analysis.
In addition, from patients who received EBT, one IVUS
cross section located at the proximal and one at the distal
junction between the treated and reference site (ie, junction
site) were selected for analysis. These junction sites in-
cluded a 1-cm nondilated segment that received EBT.
Quantitative analysis. For the assessment of lumen,
vessel, and plaque area seen on IVUS, a digital video
analyzer system (IBM Corp, Boca Raton, Fla) was used.27
The lumen area was defined as the area that was encom-
passed by the inner boundary of the intimal surface (char-
acterized also by the presence of blood). The vessel area was
defined as the area encompassed by the media-adventitia
border. The plaque area was calculated by subtracting the
lumen area from the vessel area. In point of fact, this plaque
area includes both the normal media and the intimal thick-
ening. However, because intimal thickening constitutes
most of the area of this measurement, this measurement
will be referred to as plaque area. When image quality was
inadequate or extensive dropout because of calcification
(120 degrees of the circumference) was encountered, the
analysis of vessel area could not be performed, and these
IVUS cross sections were excluded.
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Qualitative analysis. IVUS cross sections obtained
after intervention and at follow-up were evaluated for hard
lesion (ie, calcified) and dissection. Calcified lesions were
recognized with the presence of a bright echo structure
casting peripheral shadowing. For this study, a calcified
lesion was present if its arc was more than 30 degrees of the
circumference. Dissection was defined as the presence of a
tear in the intimal surface separating the lesion from the
underlying arterial wall.28
Analysis of data. First, lumen, vessel, and plaque area
measurements from each individual patient were averaged
over the number of IVUS cross sections acquired. Second,
the averaged area measurements seen immediately after
intervention and at 6-month follow-up were compared,
and the changes were calculated. First, a comparison was
made between patients without EBT and with additional
EBT after PTA in lumen, vessel, and plaque area change
seen at the treated site and at the reference site. Second, a
comparison was made between the change in lumen, vessel,
and plaque area seen at the treated site, the reference site,
and the junction site in patients with EBT. Finally, the
relation between morphologic features (ie, calcified lesion
and dissection) and the use of additional EBT was assessed.
Observers were not aware of any patient characteristics or of
the use/nonuse of EBT.
Statistical analysis. Results are given as mean  stan-
dard deviation. To analyze differences between both
groups of patients, the Student t test was used. Differences
between both groups of patients for nonparametric data
were analyzed with the Mann-Whitney test. The statistical
significance level was set at a P value of less than .05. The
reproducibility of IVUS parameters and the displacement
sensing device used in this study have been reported previ-
ously.26,29 With the information of the displacement sens-
ing device, the interobserver differences were 1.7% or less.
RESULTS
A complete IVUS follow-up (7.4  1.6 months) was
obtained in 24 (17 men, seven women) of the 38 patients.
The remaining 14 patients were excluded from the study
for the following reasons: in one patient (randomized for
EBT), additional PTA was necessary after IVUS investiga-
tion resulted in a treated segment too long for EBT; two
patients were seen with restenosis within 5 months of
follow-up (one with EBT at 3 months; one without EBT at
4 months); five patients were lost to follow-up (two with-
out and three with EBT); three patients died (no vascular
cause; one without and two with EBT); and in three
patients, IVUS investigation was not performed at fol-
low-up because of failure of the IVUS equipment (n  1;
with EBT), the presence of an iatrogene dissection as a
result of the arterial puncture (n  1; with EBT), and
occlusion of the artery (n  1; with EBT). Of the 24
patients with a complete follow-up, eight patients received
additional EBT. Table I presents demographic features,
presenting symptoms, data on the procedure, and fol-
low-up data. With regard to patient characteristics and the
procedural data, no significant difference between patients
without EBT and with EBT was seen. Angiographic, du-
plex scan, and Doppler scan values at baseline were similar.
In 38% of both groups of patients, a total occlusion was
involved. The remaining patients were seen with a stenosis.
At follow-up, angiographic restenosis was observed only in
patients without EBT (n  5). This difference between
patients without and with EBT in the occurrence of reste-
nosis was not significant (P  .08).
Change in quantitative intravascular ultrasound
scan data. In total, 441 IVUS cross sections (without
EBT, n  275; with EBT, n  166) were analyzed for the
change in lumen, vessel, and plaque area at 6-month fol-
low-up: 180 (8  3 per patient) from the treated site, 245
(10  3 per patient) from the reference site, and 16 from
the junction site (two per patient). Eight IVUS cross sec-
tions were excluded from analysis because of extensive
dropout as a result of calcification.
Table II summarizes the quantitative IVUS data de-
rived from the treated and reference sites in patients with-
out EBT and with EBT. Immediately after PTA, no signif-
icant difference in lumen, vessel, and plaque area was
encountered between both groups of patients at the treated
site and the reference site. At follow-up, at the treated site,
a significant difference between both groups of patients was
observed in the change in lumen and vessel area (Fig 1); in
patients without EBT, a decrease in lumen area of 9% and
an increase in vessel area of 2% was encountered, and in
patients with EBT, an increase in lumen and vessel area of
23% and 19%, respectively, was seen. Plaque area increase in
both groups of patients was similar (12% and 16%, respec-
tively). At the reference segment, no significant differences
between both groups of patients in lumen, vessel, and
plaque area were encountered (Table II).
Table I. Baseline patient characteristics, procedural data,
and follow-up data obtained in patients without EBT and
with EBT
Without EBT
(n  16)
With EBT
(n  8) P value
Patient characteristics
Men/women 11/5 6/2 .76
Age (years) 65.9  9.9 60.0  9.8 .18
Diabetes mellitus 3 (19%) 2 (25%) .74
Systemic hypertension 7 (44%) 5 (63%) .41
Hypercholesterolemia 4 (25%) 5 (63%) .08
Cigarette smoking 10 (63%) 7 (88%) .17
Fontaine classification
(2B/3/4)
6/6/4 6/1/1 .13
Stenosis/occlusion 10/6 5/3 1.00
Lesion length (cm) 3.4  2.9 5.2  3.3 .18
Procedure
Balloon diameter
used (4/5/6)
1/6/9 0/4/4 .89
PTA length (cm) 7.1  3.6 8.6  2.7 .33
Follow-up
Clinical restenosis 3 (19%) 1 (13%) .71
Angiographic stenosis 5 (31%) 3 (38%) .76
Restenosis 5 0 .08
de novo stenosis 0 3 .01
Data expressed as number (percentage) or as mean  standard deviation.
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Table III summarizes the quantitative IVUS data de-
rived from the treated, junction, and reference sites ac-
quired in patients with EBT. The changes in lumen, vessel,
and plaque area at the junction site were smaller (12%, 10%,
and 7%, respectively) than the changes observed at the
treated site (23%, 19%, and 16%, respectively). The dimen-
sions of the reference site remained unchanged (2%, 0%,
and 1%, respectively; Table III).
IVUS data confirmed that the restenotic lesion seen
with angiography in patients without EBT was located at
the treated site. In patients with EBT, the de novo stenosis
was seen proximal to the junction site at 1-cm, 1.5-cm, and
3.5-cm distance, respectively.
Change in qualitative intravascular ultrasound scan
data. The number of IVUS cross sections that showed a
calcified lesion was 93 (34%) immediately after PTA and
Table II. Quantitative IVUS data from treated and reference sites obtained immediately after PTA and at follow-up in
patients without EBT and with EBT
EBT After PTA (mm2) Follow-up (mm2) Change (mm2)
Treated site
Lumen area  18.3  6.9 16.6  7.4 1.6  5.1 (9%)
 18.8  6.1
(P  .86)
23.1  7.7
(P  .06)
4.3  6.8 (23%)
(P  .03)
Vessel area  36.4  12.9 37.3  12.9 0.8  5.5 (2%)
 36.8  8.6
(P  .94)
43.7  12.2
(P  .26)
6.9  8.7 (19%)
(P  .05)
Plaque area  18.3  8.8 20.6  8.6 2.2  4.0 (12%)
 17.9  6.4
(P  .91)
20.7  7.3
(P  .98)
2.8  6.0 (16%)
(P  .80)
Reference site
Lumen area  16.8  6.4 18.1  6.6 1.3  3.3 (8%)
 16.6  5.0
(P  .95)
16.3  5.0
(P  .50)
0.3  3.2 (2%)
(P  .26)
Vessel area  30.5  9.8 32.5  9.8 2.0  3.5 (7%)
 31.6  5.6
(P  .78)
31.5  5.6
(P  .80)
0.1  3.7 (0%)
(P  .20)
Plaque area  13.7  6.0 14.4  5.7 0.7  2.3 (5%)
 14.8  3.8
(P  .64)
15.0  3.6
(P  .78)
0.2  2.9 (1%)
(P  .66)
Values are mean  standard deviation.
, Without EBT; , with EBT.
Fig 1. Corresponding IVUS cross sections obtained after PTA of femoropopliteal artery (two left panels) and at
6-month follow-up (two right panels) from patient without EBT (A) and patient with EBT (B). Two middle panels show
analyzed IVUS cross sections, and outer panels represent raw data. At follow-up, patient without EBT (A) showed
decrease in both lumen and vessel area, whereas patient with EBT (B) showed increase in both lumen and vessel area.
Plaque area increase encountered in both patients (A and B) was similar. Calibration was 1 mm. , Catheter; 1,
increase;2, decrease.
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 2 Hagenaars et al 321
101 (37%) at follow-up in patients without EBT and 45
(27%) and 44 (27%), respectively, in patients with EBT. All
patients without EBT and seven of the eight patients with
EBT had a dissection immediately after PTA. In patients
without EBT, dissections observed after PTA (n  43)
were absent at follow-up. Four of the patients with EBT
had a persistent dissection at follow-up (Fig 2). The mean
arc of the dissections (n  6) in these patients decreased
from 65  29 degrees immediately after PTA to 35  12
degrees at follow-up (P  .04).
DISCUSSION
EBT has recently emerged as a promising technique to
reduce the incidence rate of restenosis after vascular inter-
vention. Clinical studies have shown that radiation therapy
in addition to PTA or stent placement in coronary arteries is
successful to reduce restenosis; at 6-month follow-up, re-
stenosis rates were reported of 8% to 22% in patients with
EBT and of 39% to 54% in patients without EBT.15,18-21 At
3-year follow-up, the restenosis rate was 33% in patients
with EBT and 64% in patients without EBT.21 Further-
more, coronary studies with radiation therapy in addition
to PTA for treatment of in-stent restenosis showed reste-
nosis rates at 6-month follow-up of 19% to 28% in patients
with EBT compared with 44% to 58% in patients without
EBT.23-25 Until now, two studies have reported on the use
of 	-radiation in femoropopliteal arteries. The first group,
represented by Minar et al,30 documented a restenosis rate
of 40% at 1-year follow-up with Doppler ultrasound scan;
in this study, 10 patients with long-segment lesions (mean,
16 cm) were included. The second group, represented by
Liermann et al,31 studied 40 patients with in-stent resteno-
sis. These patients treated with PTA and additional EBT
showed a clinical restenosis rate of 16% at follow-up (4
months to 7.5 years) with the Fontaine classification.
To the authors’ knowledge, this study represents the
first randomized study in which the effects of 	-radiation
on both plaque growth and vascular remodeling after PTA
of the femoropopliteal artery has been studied with IVUS.
This study revealed a significant difference between patients
without EBT and with EBT in lumen area change at
6-month follow-up at the treated site; in patients without
EBT, lumen area decreased 9%, whereas in patients with
EBT, an increase in lumen area of 23% was observed (Table
Table III. Quantitative IVUS data from treated site, junction site, and reference site obtained immediately after PTA
and at follow-up in patients with EBT (n  8)
Segment After PTA (mm2) Follow-up (mm2) Change (mm2)
Lumen area Treated 18.8  6.1 23.1  7.7 4.3  6.8 (23%)
Junction 17.2  4.8 19.2  5.5 2.0  5.7 (12%)
Reference 16.6  5.0 16.3  5.0 0.3  3.2 (–2%)
Vessel area Treated 36.8  8.6 43.7  12.2 6.9  8.7 (19%)
Junction 32.4  8.2 35.6  8.7 3.1  7.0 (10%)
Reference 31.6  5.6 31.5  5.6 0.1  3.7 (0%)
Plaque area Treated 17.9  6.4 20.7  7.3 2.8  6.0 (16%)
Junction 15.3  6.5 16.4  5.4 1.1  4.2 (7%)
Reference 14.8  3.8 15.0  3.6 0.2  2.9 (1%)
Values are mean  standard deviation.
Fig 2. Corresponding IVUS cross sections obtained after PTA of femoropopliteal artery (two left panels) and at
6-month follow-up (two right panels) from patient without EBT (A) and patient with EBT (B). Two middle panels show
analyzed IVUS cross sections, and outer panels represent raw data. Immediately after PTA, small dissection (arrows) was
present in both patients. At follow-up, no dissection was encountered in patient without EBT, whereas in patient with
EBT, persistent dissection (arrow) was seen. Calibration was 1 mm. , Catheter.
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II). This difference in lumen area change at follow-up was
the result of a difference in vessel area change; in patients
without EBT, vessel area remained unchanged (2%),
whereas in patients with EBT, a vessel area increase of 19%
was observed. Overall, both groups of patients showed a
similar increase in plaque area (12% and 16%, respectively).
Changes observed at the junction site were similar to the
changes at the treated site in patients with EBT (Table III).
In other words, EBT appeared to have a beneficial effect on
lumen size because of its effect on the mode of vascular
remodeling rather than on the degree of plaque growth. It
is worth mentioning that patients with EBT received an
additional dose of heparin. Theoretically, this additional
dose of heparin could have had an effect on arterial remod-
eling. However, because no difference between both
groups of patients was observed in lumen and vessel dimen-
sions at the reference segment at follow-up (Table II), the
additional dose of heparin seems unlikely to have had an
effect on vascular remodeling at follow-up.
Some issues encountered in this study deserve further
discussion.
Lumen gain at 6-month follow-up. The observation
that lumen gain after 	-radiation of the femoropopliteal
artery seen at 6-month follow-up was the result of positive
vascular remodeling confirms the effects of EBT evidenced
with IVUS in coronary arteries.16,32,33 In two of these
studies,16,32 
-radiation was used as adjunct to PTA, and in
one study,33 	-radiation was used in untreated coronary
segments. These studies showed an increase in vessel di-
mension in the presence of an increase in plaque dimension,
resulting in no change to a small increase in lumen dimen-
sion. Furthermore, in the study described by Ahmed et al,33
both patients without and with EBT were studied, and
results of their study were similar to the results seen in our
study; patients without EBT showed a decrease in vessel
dimension, whereas in patients with EBT, an increase in
vessel dimension was encountered. Both groups of patients
showed a similar increase in plaque dimension. These ob-
servations were not documented in animal studies and in
clinical studies with angiography because the latter tech-
nique only displays a silhouette of the lumen, without any
information on plaque dimensions. The importance of
IVUS in this respect is that IVUS is one of the few available
imaging techniques to document both plaque growth and
vascular remodeling.
The “edge effect” of radiation. Although the mean
lumen area at the junction site in patients with EBT in-
creased by 12% at 6-month follow-up (Table III), late
lumen loss at 1 cm and 1.5 cm proximal to the junction site
was observed in two of the three patients with an angio-
graphic de novo stenosis. IVUS data showed that the
decrease in lumen area at the stenotic lesion resulted from a
decrease in vessel area (ie, vascular shrinkage). Whether this
late lumen loss was the result of the “edge effect” (ie,
“candy-wrapper effect”) of radiation therapy or a coinci-
dental finding remains speculative. However, in a study
performed by Kozuma et al,32 in coronary arteries with

-radiation after PTA, similar results were encountered;
vessel volume at the nondilated edges in patients with EBT
decreased, whereas vessel volume at the nondilated edges in
patients without EBT remained unchanged. Plaque volume
increase in both groups of patients was similar. In contrast,
in two other IVUS studies in stented coronary arteries with
	-radiation33 or 
-radiation,34 the edge effect was not
encountered. Why these results differ from the results of
this study and the study performed by Kozuma et al32
remains speculative, but the difference may be the result of
the use of stents. Further investigation of the edge effect of
EBT may be warranted.
Persistent dissections after radiation. Although
qualitative IVUS data showed no change in the extent and
number of calcified lesions in both groups of patients,
dissections encountered immediately after PTA were absent at
follow-up in patients without EBT, whereas in four of the
eight patients (50%) with EBT, a persistent dissection was
encountered. Similar results were seen in an IVUS study
performed by Kay et al35 in coronary arteries with
-radiation.
In their study, a persistent dissection was encountered in eight
of the 16 patients (50%) with EBT at 6-month follow-up.
Results of their study raised the question of whether
persistent dissections in patients with EBT represent per-
manent dissections to the vessel wall or merely retardation
in the healing process. Because the arc of the persistent
dissections in this study decreased from 65 degrees to 35
degrees, one may conclude that EBT seems to slow the
normal healing process of the artery. However, whether
this retardation in the healing process influences lumen
dimensions in the long term needs further investigation.
Limitations. The major limitation of this study is the
small number of patients with completed IVUS follow-up
(24 of the 38 patients). Secondly, because five of the 38
patients were completely lost to follow-up, acute thrombo-
ses could have been missed. Consequently, a potential
selection bias in the patient population may have occurred.
Therefore, no conclusions can be drawn from this study
regarding the effect of EBT on restenosis. Thirdly, it would
be better to use a so-called “sham” procedure in the control
group rather than giving no additional EBT after PTA.
However, because of logistical problems, we refrained from
using a sham procedure.
CONCLUSION
This randomized IVUS study in femoropopliteal arter-
ies showed that 	-radiation after PTA: 1, has a positive
effect on lumen dimensions at 6-month follow-up by in-
ducing positive vascular remodeling; 2, seems not to reduce
plaque growth; and 3, appears to delay the healing process
of dissections after PTA.
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